A thorough list of questions to consider when dealing with the licensing of content.
A license agreement that reflects US antitrust law should be simple and straightforward. Like a well-tailored suit paired with classic pumps, it needs no frills or adornments. This article provides an overview of the primary US antitrust statutes applicable to licensing, and recommends drafting approaches to commonplace competition considerations for license agreements.
Discuss recent rules related to "famous trademarks" under Brazilian Law. Famous Trademarks are trademarks given special protection due to their recognition by a large number of consumers, quality, prestige, reputation and ability to attract consumers by their mere presence.
Last year, the Shanghai High People's Court rendered final judgment on an antitrust dispute between two Johnson & Johnson subsidiaries in China and their former distributor in Beijing. The judgment, which overturned a lower court ruling, held that the two subsidiaries were liable for damages resulting from attempts to enforce a vertical monopoly agreement against the distributor. As the first antitrust judgment relating to vertical monopoly agreements in China, the case signals the stance of the Chinese courts towards vertical trade restraints and provides guidance for future cases.
This is a sample agreement for a non-transferable, non-assignable, exclusive copyright license agreement, made between a textile and wallpaper company (“Licensee”) and an independent designer (“Licensor”). Provisions include, but are not limited to, license period, royalties, termination, indemnification, sublicenses and assignments. The agreement is governed by the laws of State of New York.
A review of United Arab Emirates law related to corporate governance, investment, incorporation, intellectual property, data privacy, real estate, and transferring shares.
The existence of a legal framework, to govern intellectual property rights, is widely recognized and appreciated in the oil and gas space. However, because of the relatively non intuitive regulatory schemes relating to creation and ownership of intellectual property rights, commercialization opportunities can easily be missed. This article highlights potential pitfalls for an oil and gas technology company in Canada and suggests ways at circumnavigating these pitfalls.
Bringing a drug to market requires an extraordinary investment. In-house counsel at biotech and pharmaceutical companies routinely face the challenge of developing an IP strategy that maximizes an investment’s return. This is especially difficult when the market for approval of a drug is relatively small. This article provides an overview of the regulatory frameworks for orphan drugs in the United States and other developed and emerging markets.
A company can maximize the value of its intellectual property by keeping current inventory and proper protection of its trademarks and copyrights. In addition, in order to strengthen partnerships and avoid legal sanctions, companies should keep a current inventory of third-party IP use. This article offers a step-by-step approach for companies looking to protect their IP assets.
This InfoPAK is not a comprehensive analysis of Intellectual Property licensing, but rather, it is a discussion of the best practices and recent developments in intellectual property licensing. The core of this InfoPAK touches on issues that are fundamental to the granting of rights, as well as the assets covered by most intellectual property licenses.